Click here to receive MS news via e-mail
Researchers have unveiled studies that show the potential for biomarkers to identify certain types of MS, and perhaps the best treatments.
Ancestry information, products for gut health, paternity tests.
One can pretty much mail order anything these days.
There are even companies that will analyze your blood without a doctor’s order. They provide blood chemistry and wellness tests based on the results.
How long before a blood sample can provide information on what type of multiple sclerosis (MS) someone has, and also how to best treat it?
Not long if clinical studies continue to show positive results with biomarkers and the potential benefits for people with MS.
Deciphering ‘snowflakes’
Biomarkers are genomic, metabolic, or lipidomic. They are used with blood tests, DNA/RNA sequences, and lipid analyses.
Recent research has shown biomarkers can be used to define MS in people, pinpoint the type of MS someone has, and provide possible hints to treatment and progression.
Biomarkers are not new.
The lumbar puncture that many people with MS receive will show a level of certain proteins, which can signal the presence of MS and help with diagnosis. But it is not enough.
MS is as unique as a snowflake. No two cases are the same, making diagnosis and treatment challenging.
If doctors could easily identify the illness, define the type of MS one has, and customize the treatment accordingly, then the patient’s chance of a healthier life is significantly higher.
In addition, people with MS could save money while fighting progression with the best medicine for their unique situation.
MS Views and News
Providing educational information, resources and services for those affected by MS, globally
MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews